Learn more

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE ROSSIJSKIJ KARDIOLOGICHESKIJ NP KOMPLEKS MIN ZDRAVOOKHRANENIJ

Overview
  • Total Patents
    28
  • GoodIP Patent Rank
    159,415
About

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE ROSSIJSKIJ KARDIOLOGICHESKIJ NP KOMPLEKS MIN ZDRAVOOKHRANENIJ has a total of 28 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Russian Federation. Its main competitors in its focus markets medical technology are CAMBRIDGE ENDOSCOPIC DEVICES, KSPINE INC and AMURSKIJ GU.

Patent filings in countries

World map showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE ROSSIJSKIJ KARDIOLOGICHESKIJ NP KOMPLEKS MIN ZDRAVOOKHRANENIJs patent filings in countries
# Country Total Patents
#1 Russian Federation 28

Patent filings per year

Chart showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE ROSSIJSKIJ KARDIOLOGICHESKIJ NP KOMPLEKS MIN ZDRAVOOKHRANENIJs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Medical technology

Focus technologies

# Technology
#1 Diagnosis and surgery

Top inventors

# Name Total Patents
#1 Rogoza Anatolij Nikolaevich 4
#2 Parfenova Elena Viktorovna 4
#3 Rubina Ksenija Andreevna 3
#4 Molokoedov Aleksandr Sergeevich 3
#5 Masenko Valerij Pavlovich 3
#6 Az Muko Andrej Andreevich 3
#7 Golitsyn Sergej Pavlovich 3
#8 Sidorova Marija Vladimirovna 3
#9 Tkachuk Vsevolod Arsen Evich 3
#10 Tereshchenko Sergej Nikolaevich 2

Latest patents

Publication Filing date Title
RU2572788C1 Method for obtaining linoleic acid
RU2571707C1 Method for optimising selecting antianginal therapy in ischemic heart disease and microvascular angina
RU2569459C1 Method of differential diagnostics of aetiology of chronic heart failure
RU2569458C1 Method of diagnostics of chronic heart failure by using circulating levels of microrna
RU2569750C1 Diagnostic technique for diabetes mellitus by measuring erythrocyte cu,zn-superoxide dismutase activity
RU2566288C1 Diagnostic technique for predisposition to atherosclerosis progression in patients with chronic ischemic heart disease as shown by peripheral blood interleukin-10 and interleukin-17 concentrations
RU2559424C1 Method for selecting drug therapy for patients with idiopathic pulmonary arterial hypertension
RU2559545C1 Method of inhibiting thrombus formation and acceleration of fibrinolysis with dna aptamers inhibiting activity of thrombin in experiment
RU2556575C1 Method for determining risk of unfavourable clinical outcome in patients with idiopathic pulmonary hypertension
RU2566287C1 Method of diagnosing in-stent restenosis
RU2549825C1 Method for assessing structural changes of atrial myocardium in patients with heart rhythm disorders
RU2542433C1 Method for preclinical study of cardiotropic antiarrhythmic drug
RU2549470C1 Crystalloid cardioplegic solutions, containing dodecapeptides (versions)
RU2536785C1 Method for determining atherosclerotic plaque mobility
RU2542964C1 Method for producing progenitor cells of myocardium
RU2531947C1 Method for prediction of risk of cardiovascular mortality in patients suffering from chronic ischemic heart failure combined with type 2 diabetes mellitus
RU2522953C1 Agent against myocardial hypoxia
RU2511059C1 Method for detecting high aortic rigidity in patients suffering cardiopathologies
RU2522778C2 Agent for treatment of ischemic lesions of tissues and method of its use
RU2502743C1 Synthetic antigen having ability to fix autoantibodies to muscarine m2-receptor